M.A. Rahman et al. / Tetrahedron Letters xxx (xxxx) xxx
3
condition using activated zinc in refluxing ethanol produced 1,3-
of compound 4 were identical to the data reported in the literature
anti diol 15 in 86% yield [7d].
[19].
The resulting allyl alcohol 15 was subjected to Sharpless asym-
i
metric epoxidation with (À)-DET, Ti(O Pr)
4 2 2
and TBHP in dry CH Cl
Scope of the protocol
to obtain epoxide 16 in 90% yield (Scheme 3). It is worthwhile to
mention here that under the given reaction condition, we did not
observed any diastereomeric product [13]. The secondary alcohol
As demonstrated, (À)-galantinic acid 1 and 1-deoxy-5-hydrox-
ysphingolipid 4 can be obtained in respectable yield using the
reported protocol. In addition, this protocol also offers an opportu-
nity to obtain other leads/principles with intriguing bioactivity [6].
Example includes, but not limited to, enigmol 24, SSR-enigmol 25,
1
6 was protected as benzyl ether using benzyl bromide and Ag
in CH Cl furnished compound 5 in 89% yield [12]. Compound 5
was then used as common precursor to obtain (À)-galantinic acid
and 1-deoxy-5-hydroxysphingolipids 4.
2
O
2
2
1
1
SRR-enigmol 26 N-methyl enigmol 27 and fumonisin B 28 (Fig. 2)
could be achieved via the minor modification of the intermediate
compounds.
Herein, we briefly describe the steps to obtain new pharma-
cophores. It should be noted that the schemes are tentative and
may require modification in more or more steps. We propose that
Synthesis of (À)-galantinic acid (1)
To synthesize (À)-galantinic acid 1, regioselective epoxide
opening of compound 5 was performed using benzyl alcohol with
1
,3-syn diol 30 can be realized by the inversion of secondary
hydroxyl functionality of 2,4,6-trisubstituted tetrahydropyran core
via Mitsunobu protocol [20] followed by reductive ring opening
Scheme 5a). The diol 30 could be further structurally modified
to obtain enigmol 24, an orally active anti-prostate cancer agent
catalytic amount of BF
3 2 2 2
.OEt in CH Cl leading to compound 17 in
9
3% yield (Scheme 3) [14]. Conversion of secondary hydroxyl group
6
(
of compound 17 to its corresponding azide under Mitsunobu reac-
tion condition furnished compound 18 in 88% yield [15]. The ter-
minal olefinic compound 18 was converted to its corresponding
[
6] and its derivative 28.
carboxylic acid 19 in 70% yield using sodium periodate (NaIO
4
)
Similarly, one can obtain leads 36 and 37 following the similar
with RuCl O catalyst [16]. Hydrogenation of compound 19
3
Á6H
2
approaches, which can be then utilized to realize compounds such
as SSR-enigmol 24 and SRR-enigmol 25 (Scheme 5b). The hydroki-
netic resolution of (±) glycidyl benzyl ether 9 using (S, S)-Jacobsen
catalyst would produce (S)-(À)-glycidyl benzyl ether 31, a precur-
sor for the isomeric amino diols. Regioselective opening of 31 ? 32
with 10% palladium on carbon (Pd/C) in MeOH yielded (À)-galan-
tinic acid [17a,4b,17b] 1 in 89% yield. The analytical data of (À)-
galantinic acid 1 were found to be similar to the data reported in
the literature [17a,b].
(
using vinyl magnesium bromide) followed by debenzylation
under Birch reduction condition would give homoallyl alcohol
3. Finally, sequential steps involving tetrahydropyran core forma-
Synthesis of 1-deoxy-5-hydroxysphingolipid (4)
3
tion (via Prins cyclization) [7], stereo-inversion (via Mitsunobu
protocol) and reductive ring opening can be used to obtain 36
and 37.
Following the successful synthesis of (À)-galantinic acid 1, our
next target was to realize 1-deoxy-5-hydroxysphingolipid 4 using
the common intermediate 5. To this end, the reductive ring open-
2 2
ing of epoxide 5 was performed using DIBAL-H in CH Cl leading to
compound 20 in 85% yield (Scheme 4). Compound 20 was sub-
jected to cross metathesis reaction with 1-dodecene using second
2 2
generation Grubbs catalyst in CH Cl under reflux condition to
afford compound 21 in 72% yield [18]. Conversion of secondary
hydroxyl functionality of compound 21 to its corresponding azide
under Mitsunobu reaction condition furnished 22 in 85% yield
(Scheme 4). Finally, compound 22 was reduced using 10% palla-
dium on carbon (Pd/C) and H in MeOH to afford 1-deoxy-5-
2
1
13
hydroxysphingolipid 4 in 91% yield. The spectral data ( H & C)
Scheme 4. Synthesis of 1-deoxy-5-hydroxysphingolipid (4). Reagent & Condi-
tions:- a) DIBAL-H, CH
CH Cl , 60 °C, 5 h, 72%; c) i) MsCl, Et
0 °C, 7 h, 85% over two steps; d) Pd/C, H
2 2
Cl , 0 °C , 6 h, 85%; b) 1-dodecene, Grubb’s 2nd (5 mol%),
2
2
3
N, CH
2
Cl
2
, 0 °C to 25 °C, 6 h; ii) NaN
OH, 18 h, 25 °C, 91%.
3
, DMF,
Fig. 2. Representative amino diols and 1-deoxy-5-hydreoxy Sphingolipids ana-
logues that can be achieved via reported protocol.
8
2
, CH
3